Abstract
Objective
Hypoglycaemic episodes and fear of hypoglycaemia can be burdensome for adults with type 1 diabetes. This study explored support needs relating to hypoglycaemia among adults with type 1 diabetes living in Denmark, Germany, the Netherlands and the United Kingdom.
Research design and methods
Respondents participated in a web‐based qualitative study involving four open‐ended questions that asked what they wished other people understood about hypoglycaemia and what other people could do differently to support them with hypoglycaemia. Responses were analyzed using reflexive thematic analysis.
Results
Participants were 219 adults with type 1 diabetes (mean ± SD age 39 ± 13 years; mean ± SD diabetes duration 20 ± 14 years). They described unmet needs relating to: (1) Clinical support, involving access to new diabetes technologies, training on hypoglycaemia prevention, personalised care and psychological support; (2) Practical support, involving family and friends better supporting them with hypoglycaemia management and prevention; (3) Education for other people, involving others becoming more informed about hypoglycaemia; and (4) An appreciation of the burden, involving others recognizing the experience and impact of episodes, and the burden of living with the risk of hypoglycaemia.
Conclusions
Adults with type 1 diabetes report several unmet support needs relating to hypoglycaemia. Service delivery should be person‐centred and prioritise the individual's support needs. Clinical conversations are needed to identify the individual's support needs and develop tailored support plans. People with diabetes and their family members should be offered hypoglycaemia‐specific education and training.
Novelty statement.
This study involved a multi‐country web‐based qualitative survey to explore support needs relating to hypoglycaemia among adults with type 1 diabetes.
Participants reported unmet needs for clinical support, practical support, education for other people and an appreciation of the burden. There were no differences in expressed needs by gender, country, experience of severe hypoglycaemia or awareness status.
The findings imply that service delivery should be person‐centred. Clinical conversations are required to identify the individual's needs and develop tailored support plans.
People with diabetes and their family members should be offered access to education and training.
Public awareness campaigns could be used to improve awareness of hypoglycaemia and reduce stigma.
1. INTRODUCTION
Self management of type 1 diabetes involves complex daily routines to achieve glycaemic targets associated with reduced risk of long‐term diabetes complications. 1 However, maintaining glucose levels within the target range can be associated with increased risk of hypoglycaemia. 2 Some adults with type 1 diabetes maintain higher glucose levels to prevent hypoglycaemia, 3 which may lead to higher HbA1c and increased risk of complications. 4 Some adults with type 1 diabetes work tirelessly to manage the risk of hypoglycaemia, to the detriment of their quality of life (QoL). 5 Consequently, hypoglycaemic episodes and fear of hypoglycaemia are associated with decreased emotional well‐being and diabetes distress among adults with type 1 diabetes. 6
Few studies have investigated the support needs of adults with type 1 diabetes in relation to the burden of hypoglycaemia. Qualitative research has revealed unmet needs for informational and emotional support, including wishes for instruction, advice, reassurance, feedback and psychological support. 7 , 8 However, these findings may only be transferable to people with type 1 diabetes with impaired awareness of hypoglycaemia (IAH) living in the United Kingdom 7 who have attended structured diabetes education. 8 The aim of the current study was to explore unmet support needs relating to hypoglycaemia among adults with type 1 diabetes across four European countries (Denmark, Germany, the Netherlands and the United Kingdom).
2. RESEARCH DESIGN AND METHODS
2.1. Design
This study involved a web‐based qualitative survey that was conducted as part of a larger study within the Hypo‐RESOLVE Project, which aimed to investigate the impact of hypoglycaemia on QoL. 9 , 10 Target countries were selected on the basis of access to personnel in the Hypo‐RESOLVE Consortium who could translate study materials into additional languages and assist with recruitment in local diabetes clinics to improve the sampling strategy. Ethics approval was granted by the University of Southern Denmark Research Ethics Committee (REC) (#19/78420), German Society for Psychology REC (#HermannsNorbert2020‐05‐12VA), Radboud University Medical Centre REC (#2020‐6587), and UK Health and Social Care REC (#20‐NI‐0054).
2.2. Participants
Across the target countries, this study was advertised in diabetes clinics, via e‐newsletters to members of diabetes associations, and on social media. Respondents were eligible to participate if they were aged ≥18 years, had a diagnosis of type 1 diabetes and were living in one of the target countries. Sample size targets were N = 50 from each country, based on past studies of QoL in people with diabetes achieving conceptual saturation with similar sample sizes. 11 Purposive sampling was used with the aim of recruiting approximately 50% of the sample with ≥1 severe hypoglycaemic episode in the past year and/or IAH, to ensure that data were being collected from individuals with recent experiences of problematic hypoglycaemia.
2.3. Materials
After completing a ‘Wheel of Life’ activity involving participants’ reflections on the impact of hypoglycaemia on QoL, 9 participants were asked four open‐ended questions about their support needs relating to hypoglycaemia (see Box 1). The questions were designed to elicit unmet needs for support from other people (including healthcare professionals, family, friends and work colleagues) to prevent, manage and live with the risk of, hypoglycaemia. The wording of questions was informed by a national survey of people with diabetes in which a single open‐ended question was used to explore participants’ wishes for support from healthcare professionals. 11 Participants were encouraged to provide as much detail as possible in their free‐text responses. Five adults with type 1 diabetes piloted the survey and provided feedback on the readability, relevance and importance of questions. The survey was then translated from English into Danish, Dutch and German in accordance with best practice guidelines. 12
BOX 1. Open‐ended questions designed to elicit unmet needs relating to hypoglycaemia.
What do you wish other people understood about hypoglycaemia?
What would you like your healthcare professional(s) to do differently to support you in avoiding or managing hypoglycaemia?
What would you like other people to do to support you in preventing and managing hypoglycaemia?
What would you tell a close friend about what it's like living with the risk of hypoglycaemia?
Participants’ demographic and clinical characteristics were assessed using validated measures and study‐specific items. Three items of the Hypoglycaemia Awareness Questionnaire (HypoA‐Q) 13 measured self‐reported frequency and severity of hypoglycaemia in the preceding 12 months. Hypoglycaemia awareness was assessed using the five‐item Impaired Awareness subscale of the HypoA‐Q 13 and the single‐item Gold. 14 Fear of hypoglycaemia was assessed using the six‐item Worry subscale of the Hypoglycemia Fear Survey Short Form (HFS‐SF). 15 Because this study was conducted during the COVID‐19 pandemic, a nine‐item adaptation of the Diabetes Attitudes, Wishes and Needs 2 (DAWN2) Impact of Diabetes Profile (DIDP) 16 was used to examine the perceived impact of the pandemic on diabetes management and other aspects of QoL likely to influence participants’ current assessment of their support needs. 17 Adaptation of the DIDP involved changing the lead‐in sentence from ‘How does diabetes impact the following aspects of your life?’ to ‘How is the COVID‐19 pandemic impacting the following aspects of your life?’, and adding ‘Diabetes’ and ‘Feelings about the future’ as items.
2.4. Data collection
The survey was hosted via REDCap, 18 an online survey platform. Respondents could participate anonymously using their computer, tablet or smartphone. First, they answered screening questions to determine their eligibility. Eligible participants were then presented with a Participant Information Sheet and invited to provide consent by selecting checkboxes. Survey responses were monitored daily to check for completeness and determine whether sample size targets had been met.
2.5. Data analysis
Survey records were imported into SPSS Version 22 and NVivo Version 12. Non‐English records were translated using Google Translate and reviewed for semantic equivalence by native speakers of the original language to preserve meaning between versions. Translated responses were analyzed using reflexive thematic analysis. 19 Two researchers (HC and MB) developed the coding framework. HC coded all responses (n = 863) and MB coded a randomly selected 20% proportion of responses (n = 166) for comparison. Agreement between coders was high (93%), with discrepancies resolved through mutual consensus.
Researchers familiarized themselves with the data, then summarized responses line‐by‐line to generate initial codes. Line‐by‐line coding involved summarizing distinct ideas within a response using as many codes as was needed. This meant that a single response could be summarized using a single code or multiple codes. Non‐meaningful responses that were unable to be interpreted, usually single word or short responses (e.g., ‘take care’ or ‘everything’), were screened out. Semantically related codes were clustered to form themes. Within‐theme extracts were then reviewed for goodness‐of‐fit, coherence and discrimination from other themes. Descriptive statistics were derived for demographic and clinical variables. Chi‐square tests were used to examine between‐group differences in support needs (by gender, country and experience of severe hypoglycaemia).
3. RESULTS
Eighteen of the 237 survey respondents did not attempt the open‐ended questions and were excluded from analyses. Those who did not attempt the open‐ended questions had higher mean fear of hypoglycaemia and were more likely to be men and engaged in unpaid work, compared to those who responded to the open‐ended questions (see Table S1). The final sample included 219 adults with type 1 diabetes, most of whom were recruited via social media (92%; n = 201). Table 1 details participants’ demographic and clinical characteristics. They had a mean ± SD age and diabetes duration of 39 ± 13 years and 20 ± 14 years, respectively. Eighty‐three percent (n = 182) were women. Sixty‐nine percent (n = 151) lived with a spouse or partner. Forty‐two percent (n = 92) were employed full time. All participants were living in one of the four target countries, which are relatively high‐income countries with universal healthcare coverage. Approximately half of the sample had attended a structured diabetes education programme (49%; n = 108). Table S2 presents between‐country differences in demographic and clinical characteristics.
TABLE 1.
Age (years) | 39.4 ± 13.3 (18–79) |
Gender | |
Women | 83.1% (182) |
Men | 16.4% (36) |
Other | 0.5% (1) |
Country of residence | |
Denmark | 18.7% (41) |
Germany | 23.3% (51) |
The Netherlands | 30.1% (66) |
United Kingdom | 27.9% (61) |
Nationality a | |
Danish | 18.3% (40) |
Dutch | 29.7% (65) |
English | 17.4% (38) |
German | 21.9% (48) |
Indian | 0.9% (2) |
Irish | 2.3% (5) |
Moroccan | 0.5% (1) |
Romanian | 0.5% (1) |
Scottish | 5.9% (13) |
Welsh | 0.9% (2) |
Other | 1.4% (3) |
Highest level of education | |
Secondary school or lower | 13.7% (30) |
Post‐secondary vocational education | 25.6% (56) |
Undergraduate (bachelor's level) education | 30.6% (67) |
Postgraduate (master's or PhD level) education | 25.6% (56) |
Other | 4.6% (10) |
Employment b | |
Full‐time | 42.0% (92) |
Part‐time | 23.3% (51) |
Self‐employed | 4.1% (9) |
Unemployed | 5.9% (13) |
Unpaid worker | 2.7% (6) |
Student | 16.4% (36) |
Retired | 5.5% (12) |
Other | 5.9% (13) |
Current living situation b | |
Alone | 16.0% (35) |
With spouse/partner | 68.9% (151) |
With child(ren) | 27.9% (61) |
With parent(s) | 11.0% (24) |
Other | 2.7% (6) |
Diabetes duration (years) | 20.4 ± 14.1 (1–64) |
Frequency of hypoglycaemia (HypoA‐Q) | |
Number of episodes (of any severity) in the past week | 3.5 (2.0–6.0) |
≥1 Episode in the past year where they needed help from others | 32.0% (70) |
Hypoglycaemia awareness status | |
Impaired (Gold score ≥4) | 39.7% (87) |
HypoA‐Q Impaired Awareness subscale c , d | 10.7 ± 2.5 (0–19) |
Problematic hypoglycaemia (≥1 severe episode in the past year and/or impaired awareness indicated by Gold score ≥4) | 55.7% (122) |
Comorbidities b | |
Diabetes complications (neuropathy, retinopathy, heart disease, vascular problems or kidney disease) | 3.8% (9) |
Other (autoimmune, psychiatric or other physical health problems) | 47.5% (114) |
None | 47.5% (114) |
Fear of hypoglycaemia (HFS‐SF Worry subscale) d , e | 10.5 ± 5.3 (0–24) |
Impact of COVID‐19 pandemic on QoL (adapted DIDP) f | |
Composite score | 3.3 ± 0.8 (1–7) |
Diabetes | 3.6 ± 1.3 (1–7) |
Sleep | 3.6 ± 1.2 (1–7) |
Physical health | 3.7 ± 1.2 (1–7) |
Emotional well‐being | 3.0 ± 1.2 (1–7) |
Financial situation | 3.7 ± 1.1 (1–7) |
Relationship with family, friends and peers | 3.3 ± 1.2 (1–7) |
Leisure activities | 2.8 ± 1.4 (1–7) |
Work or studies | 3.1 ± 1.4 (1–7) |
Feelings about the future | 3.0 ± 1.1 (1–7) |
Source of recruitment | |
Online | 91.7% (201) |
Clinic | 0.5% (1) |
Elsewhere | 7.8% (17) |
Ever attended structured diabetes education a | |
No | 48.9% (107) |
Yes | 49.3% (108) |
Within the past year | 9.5% (10) |
1–5 years ago | 17.4% (38) |
6+ years ago | 21.9% (48) |
Around time of diagnosis | 9.5% (10) |
Data are reported as percentage (n), mean ± SD (range) or median (IQR).
Percentages do not sum to 100% due to missing data.
Participants were able to select more than one response option; thus, summed percentages/ns may exceed 100%.
Higher scores indicate greater impairment of hypoglycaemia awareness (out of a possible 20).
There are no published cut‐off scores to identify individuals with clinically significant problems.
Higher scores indicate greater fear of hypoglycaemia (out of a possible 24).
Lower scores indicate more negative impact (1 = Very negative impact to 7 = Very positive impact).
Seventy‐seven percent (n = 170) of the sample used continuous glucose monitoring (CGM) or flash glucose monitoring. Fifty‐three percent (n = 116) used an insulin pump to administer insulin. Forty‐seven percent (n = 102) used multiple daily injections. Participants reported a median (IQR) of 4 (2‐6) hypoglycaemic episodes of any severity in the past week. Thirty‐two percent (n = 70) of the sample reported ≥1 severe episode in the past year (where they needed help from others/were unable to self‐treat). The frequency of severe hypoglycaemia in the past year ranged from 1 to 240 episodes per person, with a total of 624 episodes between 70 participants. Fifty‐one percent (n = 123) reported another physical/mental health diagnosis, including 4% (n = 9) with diabetes complications such as neuropathy, retinopathy, heart disease, vascular problems, or kidney disease. Thirty‐nine percent (n = 87) self‐reported IAH (Gold score ≥4). 14 Mean scores on the HypoA‐Q Impaired Awareness and HFS‐SF Worry subscales were in the middle of the range. Mean scores on the adapted DIDP revealed that participants’ overall QoL had been slightly negatively impacted by the COVID‐19 pandemic.
Of the 863 responses across the open‐ended questions, 96% (n = 830) were able to be interpreted. The median length of responses was 15 words, ranging from 1 to 293 words. Reflexive thematic analysis of meaningful responses resulted in four themes being identified: Clinical support, practical support, education for other people and an appreciation of the burden. Table 2 presents codes within each theme, as well as participant quotations and the number of coded extracts within each code. Chi‐square tests indicated significant between‐country differences in practical support needs (p = 0.038); however, post hoc tests revealed no significant contrasts between countries. There were no further differences in the number of coded extracts by gender, country or experience of severe hypoglycaemia (see Tables S3–S5).
TABLE 2.
Themes/codes | Quotation | Number of extracts a (N = 1088) |
---|---|---|
Clinical support | 181 | |
Access to new diabetes technologies | Give me a CGM so that I KNOW what my levels are… gives reassurance and prevents ‘just in case’ over‐treatment. (47‐year‐old woman from the UK) | 61 |
Training on hypoglycaemia prevention | It would have made sense to have training earlier on so that you don't have to learn everything painfully. (31‐year‐old man from Germany) | 50 |
Personalised care | Really look closely at the causes of hypoglycaemia and work with me to eliminate them. (26‐year‐old woman from the Netherlands) | 53 |
Psychological support | For me, it is more the psychological aspect of living with the risk that creates problems. That part, I do not really expect doctors and nurses to be able to take complete care of, but it is important when discussing the behavioural steps a diabetic can take to be well regulated. (34‐year‐old male from Denmark) | 5 |
Positive experiences with HCPs | My practitioner has trained me well and is at my side with advice/action. (35‐year‐old man from Denmark) | 12 |
Practical support | 193 | |
Remain calm during episodes | Don't make a fuss. Don't attract attention. Just offer something like orange juice and quietly support me. Don't expect interaction as I recover. (40‐year‐old woman from the UK) | 161 |
Help with hypoglycaemia prevention | Take hypo into account when undertaking spontaneous activities. Ask if this works before an activity. (23‐year‐old woman from the Netherlands) | 32 |
Education for other people | 179 | |
General knowledge about hypoglycaemia | Know the difference between a hypo and a hyper, the symptoms, and what the person should ultimately do in that situation. (21‐year‐old woman from the UK) | 135 |
Understanding of the seriousness | You don't just have a craving for sweets; it is a painful struggle for survival. (25‐year‐old male from Germany) | 30 |
Symptoms can vary | That not every hypo feels the same. I have the impression that some people sometimes think that you are acting, because sometimes you can still function well during a hypo. (30‐year‐old female from the Netherlands) | 14 |
Appreciation of the burden | 535 | |
Experience of episodes and their impact | I am not immediately available again just because my sugars have come back up; no demands should be placed on me. (25‐year‐old female from Denmark) | 241 |
Living with the risk of hypoglycaemia | It feels as if, at almost every moment, you are at risk of needing help to survive, simply on the basis of a minor calculation error. It takes so much focus and the heart of a gambler to push the boundaries of the usual routine. (34‐year‐old male from Denmark) | 294 |
Extracts may be coded to more than one theme.
3.1. Clinical support
3.1.1. Access to new diabetes technologies
Participants believed that new technologies could help them to better predict low glucose and understand their glycaemic patterns so that they could retain hypoglycaemia awareness, optimize their glucose levels, and have a normal life. Some mentioned that they required assistance to seek reimbursement for the financial costs of new devices. Others wished for costs to be covered by the public healthcare system. Participants stated that new technologies should be offered even if a person's diabetes is not poorly controlled, as it seems like a punishment that I’m not entitled to a Libre as I am too well regulated, whereas a Libre might help me avoid the hypoglycaemia I do have. Some wished for closed loop systems to be approved and for problems with their current devices to be resolved (e.g. false alarms on their CGM).
3.1.2. Training on hypoglycaemia prevention
Participants lacked information about the causes, symptoms and consequences of hypoglycaemia. They wanted more training on how to recognize, prevent and manage hypoglycaemia. Some stated that healthcare professionals could have provided this information and training earlier on, so that they could have been better informed and more prepared. Participants wished for healthcare professionals to address their concerns with diet, exercise and weight loss in the context of hypoglycaemia management.
3.1.3. Personalised care
Participants wanted healthcare professionals to examine the causes of their recent hypoglycaemic episodes and provide personalised advice on how to prevent future episodes. They explained that healthcare professionals should avoid giving generic advice and instead give you the feeling that they are really thinking about it. They wished for healthcare professionals to take the time to look at recorded values, analyse glycaemic patterns and make necessary adjustments to their insulin regimen. Some indicated that they wished for healthcare professionals to show more compassion, avoid judgment and be mindful of their language: Don't call it a snack, it makes me feel like a child. Call it a hypo treatment. More generally, they wanted healthcare professionals to talk more about hypoglycaemia during clinical consultations, such that it becomes a less shameful topic.
3.1.4. Psychological support
Participants reported a need for psychological support to manage their fear and anxiety relating to living with the risk of hypoglycaemia. They suggested that their diabetes practitioner could offer emotional support or refer them to an experienced psychologist who specializes in hypo anxiety.
3.1.5. Positive experiences with HCPs
Some participants stated that they were well supported by their healthcare professionals, who had prescribed CGM and referred them to a dietitian or hypoglycaemia awareness course, as needed. They explained that they had good dialogue with their healthcare professionals and could think about things together. Others mentioned that the responsibility [of hypoglycaemia prevention and management] does not lie with the practitioner and that it is the task of the patient.
3.2. Practical support
3.2.1. Remain calm during episodes
Participants emphasized the need for others to remain calm during episodes, despite the seriousness of the situation. They explained that the panic of my friends or colleagues makes it worse and wished for others to understand that hypoglycaemia can be resolved quickly with appropriate treatment. Participants wanted others to ask how they can help without making a fuss or criticizing them. They did not appreciate others telling me what I did wrong and wanted no discussions, no patronizing, no know‐it‐all, positive feedback only. Participants stated that others should offer an appropriate hypoglycaemia treatment as soon as possible, then give them time and space to recover from hypoglycaemia and respect that we know what we are doing. Some expressed a need for others to take over and ensure their safety when they are no longer able to care for themselves. Others described a preference to be left alone.
3.2.2. Help with hypoglycaemia prevention
Participants wanted family and friends to carry emergency hypoglycaemia treatments, help them with healthy eating and carbohydrate counting, and keep hypoglycaemia in mind when planning activities with them. They suggested that others could help by monitoring for the first signs of hypoglycaemia and being ready to point them out. Some wished their employers would offer them more flexibility in terms of modifying their work hours or taking meal breaks as needed to manage hypoglycaemia.
3.3. Education for other people
3.3.1. General knowledge about hypoglycaemia
Participants wanted their family, friends, colleagues and the public to become more informed about the symptoms and treatment of hypoglycaemia, including what to do to help if needed. They wanted common misunderstandings to be corrected: It should be treated with glucose, NOT insulin; hyperglycaemia and hypoglycaemia are often swapped around. Some wished for educational resources and training courses for their family and friends. Others proposed leaflets for their work colleagues and awareness campaigns for the public. They explained that, if others had a better understanding of the symptoms (i.e. cognitive and behavioural changes), they could avoid situations in which their hypoglycaemia is mistaken for intoxication.
3.3.2. Understanding of the seriousness
Participants mentioned that family, friends, and the public often underestimate what [hypoglycaemia] is. They wished for others to understand that hypoglycaemia can be dangerous and lead to seizure, coma and long‐term cognitive impairment. They explained that episodes can be life‐threatening, so they must act immediately: It can be lethal. If you're not sure whether it's a hypo, treat it as if it is.
3.3.3. Symptoms can vary
Participants wanted their family and friends to be aware that episodes can vary greatly in terms of their symptoms and severity, such that they may not look the same each time. They explained that they may appear as if they are functioning well, but they are in fact much worse off. In addition, hypoglycaemic episodes differ in terms of impact and recovery time, with some episodes able to be treated on the run and others necessitating longer periods of rest.
3.4. Appreciation of the burden
3.4.1. Experience of episodes and their impact
Participants wished that others could understand how [hypoglycaemia] feels in the mind and body, namely the acute discomfort and unpleasantness. They wanted family and friends to recognize that they find it difficult to manage their mood during episodes: I'm not myself in that moment; some things I say are snappy or argumentative, but they are not meant that way. Participants wanted others to understand the emotional impact of hypoglycaemia, including their feelings of self‐blame, frustration, anger, disappointment, [feeling] stupid and misunderstood, helplessness, powerlessness, loneliness, sadness and discontentment. They wished for others to appreciate that episodes are physically and mentally exhausting, and that it can take a long time to fully recover.
3.4.2. Living with the risk of hypoglycaemia
Participants wanted others to recognize that they greatly fear hypoglycaemia: It hangs over your head all the time. They wished for others to appreciate that they feel drained from always thinking about/working on [hypoglycaemia prevention] and never having time off. They wanted their family and healthcare professionals to be more understanding of the fact that some episodes are unavoidable despite their best efforts: They have nothing to do with a bad attitude or lack of care for your condition. They stated that episodes are never deliberate or intentional, so they should not be blamed for recurrences: It can happen at any time and it's not my fault. Participants wanted others to recognize that their lives were severely limited by hypoglycaemia and they were often unable to be as spontaneous as they would like. Some explained that the risk of hypoglycaemia could be managed with the right preparation and attention, but that other people should understand that this is annoying and a nuisance.
4. DISCUSSION
This multi‐country, web‐based, qualitative study highlights several unmet support needs relating to hypoglycaemia among adults with type 1 diabetes. While participants mentioned satisfaction with some aspects of the support they received, the majority expressed unmet needs for clinical support, practical support, education for other people and an appreciation of the burden of hypoglycaemia. The finding that participants wanted more structured clinical support and more understanding from other people is consistent with previous studies of support needs relating to diabetes self management more broadly. 11 , 20 In addition, this study revealed several novel findings in terms of unmet needs relating specifically to hypoglycaemia.
Participants wanted healthcare professionals to address their personal challenges with hypoglycaemia and provide personalised, rather than generic, advice. This finding may indicate that adults with type 1 diabetes do not always perceive themselves to be at the centre of their diabetes care. Participants further reported divergent wishes for others’ involvement in hypoglycaemia management, whereby some wanted family and friends to be actively involved during episodes, and others wished to be left alone. This finding indicates that an individual's preferences cannot be assumed and that conversations are required to ascertain the individual's wishes.
The most frequently cited theme was the need for other people to appreciate the burden of hypoglycaemia. Participants described feeling misunderstood, judged, or blamed for recurrences of hypoglycaemia. Given the physical, psychological and social consequences of diabetes‐related stigma, 21 this finding indicates that stigma‐reducing interventions and mitigating strategies are needed. Public awareness campaigns could help to improve awareness of hypoglycaemia and minimize societal stigmatization. Adults with type 1 diabetes could be offered peer support and/or counselling to mitigate the personal impact of stigma.
4.1. Strengths and limitations
Data were collected from a large, heterogeneous, multi‐country (albeit mostly European) sample. The web‐based survey format enabled recruitment of groups that are hardly reached and offered participants the opportunity to consider their responses carefully. The fact that participants were assured anonymity likely promoted more candid responses, though the ‘Wheel of Life’ activity that preceded open‐ended questions may have additionally increased the depth of participants’ responses to open‐ended questions about support needs. Participants reported that the COVID‐19 pandemic had had a slightly negative impact on their overall QoL, which could have influenced their expressed needs and the degree to which those needs were currently being met.
This study may have been biased towards recruitment of socially advantaged participants, including those with internet access and greater engagement with social media. Web‐based data collection further meant that researchers were unable to seek clarification from participants where their meaning was unclear, though the findings are largely consistent with past research. 7 , 8 While the sampling strategy was aimed at recruiting participants with severe hypoglycaemia and/or IAH, this study was likely subject to self‐selection bias. There was a higher rate of IAH in this sample compared to previous studies with unselected cohorts. 22 Nonetheless, the majority self‐reported intact awareness and there were no significant differences observed between the free‐text responses of people with intact and impaired awareness.
The finding that there were no between‐country differences suggests that support needs may be similar for adults with type 1 diabetes in the four countries targeted. Since the participants were from high‐income countries with universal healthcare coverage, the findings may be less transferable to adults with type 1 diabetes living in lower‐income countries with less access to resources, including structured diabetes education. Further research is needed to examine the support needs of adults with type 1 diabetes from different cultural backgrounds, as their experiences of hypoglycaemia may differ. 23 Finally, it should be noted that there was an over‐representation of women in this sample, though there were no significant differences observed between the free‐text responses of men and women. Future studies should further explore hypoglycaemia‐related support needs among men with type 1 diabetes, especially given emerging sex differences in the incidence of severe hypoglycaemia. 24
4.2. Implications
The findings imply that service delivery should be person‐centred and prioritise the individual's support needs. Past research shows that a person‐centred approach to diabetes care is associated with significant improvements in clinical outcomes. 25 Most participants in this study reported no episodes of severe hypoglycaemia in the past year and intact hypoglycaemia awareness, which suggests that the presence of severe hypoglycaemia and IAH are not the only indicators of need. Some individuals may wish to prioritize their needs relating to diabetes management more broadly, whereas others may wish to address their needs relating to the unique challenges of hypoglycaemia.
Participants in this study indicated that hypoglycaemia was a shameful topic to talk about in clinical consultations as it was not regularly discussed. Clinicians should ask individuals about their experiences of hypoglycaemia and associated needs for support, which could help to normalize discussion of hypoglycaemia. In doing so, clinicians should use respectful and non‐judgemental language, and ask open‐ended questions in a sensitive way. 26 Clinicians should be aware that individuals may be reluctant to talk openly about hypoglycaemia due to previous experiences of judgement. 11 Clinical tools, such as the Type 1 Diabetes Consultation (T1C) Tool, 27 could be used to guide discussion of support needs. Gaining a better understanding of an individual's support needs is key to developing tailored support plans that will suit the person's circumstances.
The finding that adults with type 1 diabetes and their family members lacked hypoglycaemia‐specific information and training indicates that access to education needs to be improved. This likely requires intervention at many levels. First, adults with type 1 diabetes should be offered access to structured education programmes. Programmes should address how to prevent, recognize and manage hypoglycaemia, with some focus on diet, weight management and physical activity, as suggested by participants. While some may benefit from this education as early as possible such that they feel more informed, others may find this overwhelming. Some may benefit from peer support groups with other people with diabetes, where they can learn practical tips that are more easily implemented in their everyday life. 28 Second, family members could be included in discussions about diabetes care and offered hypoglycaemia‐related information. Third, diabetes associations could develop information leaflets that people with diabetes could share with their family, friends and colleagues.
Finally, diabetes associations could implement awareness campaigns aimed at educating the public about hypoglycaemia and reducing stigma, such as broader implementation of the Australian and USA‐based ‘Lowdown’ campaigns. Although some of the unmet needs described by participants in this study could be addressed with person‐centred care, others would require systemic or policy‐level changes (e.g. healthcare systems funding new diabetes technologies).
4.3. Conclusion
Adults with type 1 diabetes report several unmet needs for support in preventing, managing, and living with the risk of hypoglycaemia. The variation in expressed needs indicates that conversations are required to identify the individual's needs and address the burden of hypoglycaemia. Service delivery needs to be person‐centred to ensure that the individual's support needs are met. People with diabetes and their family members should be offered access to education and training. Public awareness campaigns could be used to improve awareness of hypoglycaemia and reduce stigma.
CONFLICT OF INTEREST
The authors declare no conflicts of interest.
Supporting information
ACKNOWLEDGEMENTS
The authors thank the adults with type 1 diabetes who participated in this study. The authors acknowledge Mette Valdersdorf Jensen, Manon Coolen, and Kevin Matlock (University of Southern Denmark) who contributed to development of the study concept, design, and protocol. The authors acknowledge Uffe Søholm, Nanna Lindekilde, Mette Valdersdorf Jensen and Manon Coolen (University of Southern Denmark) who translated survey materials.
Chatwin H, Broadley M, Hendrieckx C, et al; On behalf ofthe Hypo‐RESOLVE Consortium . Unmet support needs relating to hypoglycaemia among adults with type 1 diabetes: Results of a multi‐country web‐based qualitative study. Diabet Med. 2022;39:e14727. doi: 10.1111/dme.14727
Funding information
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement #777460. The JU receives support from the European Union's Horizon 2020 Research and Innovation Programme and EFPIA and T1D Exchange, JDRF, International Diabetes Federation (IDF), The Leona M. and Harry B. Helmsley Charitable Trust. CH and JS are supported by core funding to the Australian Centre for Behavioural Research in Diabetes provided by the collaboration between Diabetes Victoria and Deakin University.
REFERENCES
- 1. American Diabetes Association . 6. Glycemic targets: standards of medical care in diabetes—2021. Diabetes Care. 2021;44(Supplement 1):S73‐S84. [DOI] [PubMed] [Google Scholar]
- 2. Cryer PE. Glycemic goals in diabetes: trade‐off between glycemic control and iatrogenic hypoglycemia. Diabetes. 2014;63(7):2188‐2195. [DOI] [PubMed] [Google Scholar]
- 3. Dømgaard M, Bagger M, Rhee NA, Burton CM, Thorsteinsson B. Individual and societal consequences of hypoglycemia: a cross‐sectional survey. Postgrad Med. 2015;127(5):438‐445. [DOI] [PubMed] [Google Scholar]
- 4. Wild D, von Maltzahn R, Brohan E, Christensen T, Clauson P, Gonder‐Frederick L. A critical review of the literature on fear of hypoglycemia in diabetes: implications for diabetes management and patient education. Patient Educ Couns. 2007;68(1):10‐15. [DOI] [PubMed] [Google Scholar]
- 5. Speight J, Holmes‐Truscott E, Hendrieckx C, Skovlund S, Cooke D. Assessing the impact of diabetes on quality of life: what have the past 25 years taught us? Diabetes Care. 2020;37(3):483‐492. [DOI] [PubMed] [Google Scholar]
- 6. Chatwin H, Broadley M, Speight J, et al. The impact of hypoglycaemia on quality of life outcomes among adults with type 1 diabetes: a systematic review. Diabetes Res Clin Pract. 2021;174:108752. [DOI] [PubMed] [Google Scholar]
- 7. Rankin D, Elliott J, Heller S, et al. Experiences of hypoglycaemia unawareness amongst people with type 1 diabetes: a qualitative investigation. Chronic Illness. 2014;10(3):180‐191. [DOI] [PubMed] [Google Scholar]
- 8. Lawton J, Rankin D, Cooke DD, et al. Self‐treating hypoglycaemia: a longitudinal qualitative investigation of the experiences and views of people with Type 1 diabetes. Diabet Med. 2013;30(2):209‐215. [DOI] [PubMed] [Google Scholar]
- 9. Chatwin H, Broadley M, Valdersdorf Jensen M, et al. “Never again will I be carefree”: a qualitative study of the impact of hypoglycemia on quality of life among adults with type 1 diabetes. BMJ Open Diabetes Research & Care. 2021;9:e002322. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Galan BE, McCrimmon RJ, Ibberson M, et al. Reducing the burden of hypoglycaemia in people with diabetes through increased understanding: design of the Hypoglycaemia REdefining SOLutions for better liVEs (Hypo‐RESOLVE) project. Diabet Med. 2020;37(6):1066‐1073. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Litterbach E, Holmes‐Truscott E, Pouwer F, Speight J, Hendrieckx C. ‘I wish my health professionals understood that it's not just all about your HbA1c!’. Qualitative responses from the second Diabetes MILES–Australia (MILES‐2) study. Diabet Med. 2020;37(6):971‐981. [DOI] [PubMed] [Google Scholar]
- 12. Wild D, Grove A, Martin M, et al. Principles of good practice for the translation and cultural adaptation process for patient‐reported outcomes (PRO) measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health. 2005;8(2):94‐104. [DOI] [PubMed] [Google Scholar]
- 13. Speight J, Barendse SM, Singh H, et al. Characterizing problematic hypoglycaemia: iterative design and preliminary psychometric validation of the Hypoglycaemia Awareness Questionnaire (HypoA‐Q). Diabet Med. 2016;33(3):376‐385. [DOI] [PubMed] [Google Scholar]
- 14. Gold AE, MacLeod KM, Frier BM. Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care. 1994;17:697‐703. [DOI] [PubMed] [Google Scholar]
- 15. Grabman J, Vajda Bailey K, Schmidt K, et al. An empirically derived short form of the Hypoglycaemia Fear Survey II. Diabet Med. 2017;34(4):500‐504. [DOI] [PubMed] [Google Scholar]
- 16. Peyrot M, Burns KK, Davies M, et al. Diabetes Attitudes Wishes and Needs 2 (DAWN2): a multinational, multi‐stakeholder study of psychosocial issues in diabetes and person‐centred diabetes care. Diabetes Res Clin Pract. 2013;99(2):174‐184. [DOI] [PubMed] [Google Scholar]
- 17. Sacre JW, Holmes‐Truscott E, Salim A, et al. Impact of the COVID‐19 pandemic and lockdown restrictions on psychosocial and behavioural outcomes among Australian adults with type 2 diabetes: findings from the PREDICT cohort study. Diabet Med. 2021:e14611. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata‐driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377‐381. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Braun V, Clarke V. Reflecting on reflexive thematic analysis. Qualitative Res Sport, Exercise Health. 2019;11(4):589‐597. [Google Scholar]
- 20. Rogers H, De Zoysa N, Amiel S. Patient experience of hypoglycaemia unawareness in Type 1 diabetes: are patients appropriately concerned? Diabet Med. 2012;29(3):321‐327. [DOI] [PubMed] [Google Scholar]
- 21. Schabert J, Browne J, Mosely K, Speight J. Social stigma in diabetes: a framework to understand a growing problem for an increasing epidemic. The Patient: Patient‐centered Outcomes Research. 2013;6(1):1‐10. [DOI] [PubMed] [Google Scholar]
- 22. ter Braak EW, Appelman AM, van de Laak M, Stolk RP, van Haeften TW, Erkelens DW. Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia. Diabetes Care. 2000;23(10):1467‐1471. [DOI] [PubMed] [Google Scholar]
- 23. Khunti K, Alsifri S, Aronson R, et al. Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin‐treated type 1 and type 2 diabetes: the global HAT study. Diabetes Obes Metab. 2016;18(9):907‐915. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Hendrieckx C, Halliday JA, Bowden JP, et al. Severe hypoglycaemia and its association with psychological well‐being in Australian adults with type 1 diabetes attending specialist tertiary clinics. Diabetes Res Clin Pract. 2014;103(3):430‐436. [DOI] [PubMed] [Google Scholar]
- 25. Rutten GE, Van Vugt H, de Koning E. Person‐centered diabetes care and patient activation in people with type 2 diabetes. Bmj Open Diabetes Research & Care. 2020;8(2):e001926. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Speight J, Skinner T, Dunning T, et al. Our language matters: Improving communication with and about people with diabetes. A position statement by Diabetes Australia. Diabetes Res Clin Pract. 2021;173. [DOI] [PubMed] [Google Scholar]
- 27. Todd PJ, Edwards F, Spratling L, et al. Evaluating the relationships of hypoglycaemia and HbA1c with screening‐detected diabetes distress in type 1 diabetes. Endocrinology, Diabetes & Metabolism. 2018;1(1):e00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Due‐Christensen M, Willaing I, Ismail K, Forbes A. Learning about Type 1 diabetes and learning to live with it when diagnosed in adulthood: two distinct but inter‐related psychological processes of adaptation A qualitative longitudinal study. Diabet Med. 2019;36(6):742‐752. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.